Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Severe underestimation of COVID-19 case numbers: effect of epidemic growth rate and test restrictions

Peter Richterich
doi: https://doi.org/10.1101/2020.04.13.20064220
Peter Richterich
CodonCode Corporation, Centerville MA 02632, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: peter.richterich@codoncode.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

To understand the scope and development of the COVID-19 pandemic, knowledge of the number of infected persons is essential. Often, the number of “confirmed cases”, which is based on positive RT-PCR test results, is regarded as a reasonable indicator. However, limited COVID-19 test capacities in many countries are restricting the amount of testing that can be done. This can lead to the implementation of testing policies that restrict access to COVID-19 tests, and to testing backlogs and delays. As a result, confirmed case numbers can be significantly lower than the actual number of infections, especially during rapid growth phases of the epidemic.

This study examines the quantitative relation between infections and reported confirmed case numbers for two different testing strategies, “limited” and “inclusive” testing, in relation to the growth rate of the epidemic. The results indicate that confirmed case numbers understate the actual number of infections substantially; during rapid growth phases where the daily growth rate can reach or exceed 30%, as has been seen in many countries, the confirmed case numbers under-report actual infections by up to 50 to 100-fold.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received for this study.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data used for this study were downloaded from the public repository at https://github.com/CSSEGISandData/COVID-19/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted April 17, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Severe underestimation of COVID-19 case numbers: effect of epidemic growth rate and test restrictions
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Severe underestimation of COVID-19 case numbers: effect of epidemic growth rate and test restrictions
Peter Richterich
medRxiv 2020.04.13.20064220; doi: https://doi.org/10.1101/2020.04.13.20064220
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Severe underestimation of COVID-19 case numbers: effect of epidemic growth rate and test restrictions
Peter Richterich
medRxiv 2020.04.13.20064220; doi: https://doi.org/10.1101/2020.04.13.20064220

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1437)
  • Dentistry and Oral Medicine (221)
  • Dermatology (158)
  • Emergency Medicine (293)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (590)
  • Epidemiology (10339)
  • Forensic Medicine (6)
  • Gastroenterology (534)
  • Genetic and Genomic Medicine (2658)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1746)
  • Health Policy (791)
  • Health Systems and Quality Improvement (683)
  • Hematology (270)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12123)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2486)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (498)
  • Occupational and Environmental Health (569)
  • Oncology (1338)
  • Ophthalmology (404)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (787)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2424)
  • Public and Global Health (5035)
  • Radiology and Imaging (903)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (258)
  • Sports Medicine (246)
  • Surgery (301)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)